Cargando…
Potential Patient-Reported Toxicities With Disulfiram Treatment in Late Disseminated Lyme Disease
Recently, disulfiram has been proposed as a promising treatment for people suffering from persistent symptoms of Lyme Disease. Disulfiram has several distinct molecular targets. The most well-known is alcohol dehydrogenase, a key enzyme for detoxifying the organism after alcohol ingestion. Other tar...
Autores principales: | Trautmann, Alain, Gascan, Hugues, Ghozzi, Raouf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184924/ https://www.ncbi.nlm.nih.gov/pubmed/32373619 http://dx.doi.org/10.3389/fmed.2020.00133 |
Ejemplares similares
-
Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases
por: Liegner, Kenneth B.
Publicado: (2019) -
A Unique Case of Bannwarth Syndrome in Early Disseminated Lyme Disease
por: Omotosho, Yetunde B, et al.
Publicado: (2021) -
Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
por: Rebman, Alison W., et al.
Publicado: (2020) -
“Repurposing” Disulfiram in the Treatment of Lyme Disease and Babesiosis: Retrospective Review of First 3 Years’ Experience in One Medical Practice
por: Gao, Jiachen, et al.
Publicado: (2020) -
Late Disseminated Lyme Disease: Associated Pathology and Spirochete Persistence Posttreatment in Rhesus Macaques
por: Crossland, Nicholas A., et al.
Publicado: (2018)